Thinking of Prescribing an Opioid? Did You Check Your State Prescription Drug Monitoring Program? (PDF - 149 KB)
Lists the benefits of registering with a prescription drug monitoring program.
This collection of tools and resources is for providers, staff, and patients who offer or use services to address substance use, and other interested stakeholders. This collection was originally established following an environmental scan on implementing medication-assisted treatment (MAT) for opioid use disorder (OUD) in rural primary care. (See PDFs of Volume 1 (PDF - 609 KB) and Volume 2 (PDF - 1.3 MB) of that scan). Items have been continuously added to this collection since then, and the collection has expanded to cover substance use more broadly, rather than just MAT for OUD.
Lists the benefits of registering with a prescription drug monitoring program.
Assists clinicians and administrators in implementing behavioral healthcare using telehealth by offering key considerations and examples of using telehealth for behavioral health
Assesses patients' treatment needs and whether they would be good candidates for office-based opioid treatment.
Provides a quick targeted screening in clinical and research settings with an 8-item measure.
Describes how to more effectively and safely manage patients seeking care for acute pain and encourages the clinician to carefully consider unintended consequences (abuse, misuse, overdose, addiction, and diversion) when prescribing opioids.
Provides a template for an agreement that describes the patient's responsibilities and commitment not to engage in certain activities.
Collaborative Care is a new way of doing medicine and requires an openness to creating a new vision that everyone supports. This step-by-step guide provides a broad overview of the major steps needed to successfully implement a Collaborative Care program.
These guidelines contain recommendations on the identification and management of substance use and substance use disorders for health care services which assist women who are pregnant, or have recently had a child, and who use alcohol or drugs or who have a substance use disorder.
Uses graphics and a description of the pharmacology to explain buprenorphine in lay terms.